EMEA-001114-PIP01-10-M03

  • Email
  • Help

Overview

Product details for Elocta
Invented nameElocta
Active substance

Efmorocotocog alfa

Decision numberP/0149/2016
PIP numberEMEA-001114-PIP01-10-M03
Pharmaceutical form(s)Powder and solvent for solution for injection
Condition(s)/indication(s)

Treatment of hereditary factor-VIII deficiency

Route(s) of administrationIntravenous use
PIP applicant

Biogen Idec Ltd
United Kingdom
Tel. +44 (0) 16285 12609 / 44 (0)7557057823
Fax +44 (0) 16285 12696
E-mail: amit.patel@biogen.cpm

Decision typePM: decision on the application for modification of an agreed PIP

Decision

Related information